CSIMarket
 


Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Genocea Biosciences Inc 's Leverage Ratio

GNCA's quarterly Leverage Ratio and Total Liabilities, Equity growth




GNCA Leverage Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Change 108.71 % 241.4 % 382.81 % 177.23 % -57.2 %
Y / Y Total Liabilities Change 58.28 % 67.17 % 19.83 % 99.72 % 26.63 %
Leverage Ratio MRQ 2.47 1.1 0.61 0.84 3.26
Overall Ranking # # # # #
Seq. Equity Change -48.04 % -20.18 % -18.38 % 516.49 % -15 %
Seq. Total Liabilities Change 16.72 % 44.26 % -40.88 % 59 % 23.27 %



Leverage Ratio first quarter 2020 Comment
Due to net new borrowings of 16.72%, Leverage Ratio detoriated to 2.47, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2020, 9 other companies have achieved lower Leverage Ratio than Genocea Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are GNCA Customers?
Leverage Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 10
Healthcare Sector # 73
Overall Market # 536


Leverage Ratio Statistics
High Average Low
4.89 1.08 0.14
(Sep 30 2017)   (Sep 30 2015)




Financial Statements
Genocea Biosciences Inc 's Equity $ 13 Millions Visit GNCA's Balance sheet
Genocea Biosciences Inc 's Total Liabilities $ 32 Millions Visit GNCA's Balance sheet
Source of GNCA's Sales Visit GNCA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Leverage RatioMar 31 2020 MRQ Total LiabilitiesMar 31 2020 MRQ Equity
Wave Life Sciences Ltd   6.15 $ 128.376  Millions$ 20.858  Millions
Amgen Inc   5.46 $ 51,757.000  Millions$ 9,485.000  Millions
Cytomx Therapeutics Inc   5.26 $ 366.895  Millions$ 69.767  Millions
Integrated Biopharma Inc  3.98 $ 16.501  Millions$ 4.144  Millions
Intelgenx Technologies Corp   3.68 $ 9.993  Millions$ 2.714  Millions
Pulmatrix Inc   3.37 $ 23.375  Millions$ 6.936  Millions
Genocea Biosciences Inc   2.47 $ 32.179  Millions$ 13.013  Millions
Aerie Pharmaceuticals Inc   2.24 $ 285.068  Millions$ 127.209  Millions
Tracon Pharmaceuticals Inc   2.17 $ 6.053  Millions$ 2.784  Millions
Immunomedics Inc   2.16 $ 400.295  Millions$ 184.911  Millions
Cel Sci Corp  1.84 $ 22.509  Millions$ 12.209  Millions
Soligenix Inc   1.78 $ 6.245  Millions$ 3.515  Millions
Nanostring Technologies Inc   1.70 $ 229.741  Millions$ 135.134  Millions
Azurrx Biopharma Inc   1.69 $ 5.143  Millions$ 3.041  Millions
Coherus Biosciences inc   1.55 $ 243.107  Millions$ 157.275  Millions
Gilead Sciences Inc   1.54 $ 34,217.000  Millions$ 22,179.000  Millions
Allergan plc  1.49 $ 86,283.400  Millions$ 58,021.500  Millions
Galera Therapeutics Inc   1.47 $ 77.755  Millions$ 53.058  Millions
Acorda Therapeutics inc   1.46 $ 447.153  Millions$ 306.674  Millions
Neuronetics Inc   1.32 $ 48.014  Millions$ 36.511  Millions
Brickell Biotech Inc   1.20 $ 7.091  Millions$ 5.894  Millions
Adma Biologics Inc   1.18 $ 114.045  Millions$ 96.336  Millions
Allena Pharmaceuticals Inc   1.18 $ 12.585  Millions$ 10.658  Millions
Protagonist Therapeutics Inc   1.15 $ 72.235  Millions$ 62.666  Millions
Chromadex Corp   1.15 $ 19.062  Millions$ 16.548  Millions
Emergent Biosolutions Inc   1.12 $ 1,203.900  Millions$ 1,074.800  Millions
Sellas Life Sciences Group Inc   1.10 $ 8.841  Millions$ 8.062  Millions
Biogen Inc   1.08 $ 13,572.300  Millions$ 12,536.900  Millions
Merus N v   1.08 $ 123.376  Millions$ 114.586  Millions
Eiger Biopharmaceuticals Inc   1.01 $ 43.463  Millions$ 43.221  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MHH's Profile

Stock Price

MHH's Financials

Business Description

Fundamentals

Charts & Quotes

MHH's News

Suppliers

MHH's Competitors

Customers & Markets

Economic Indicators

MHH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071